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Arsenic as a Teratogenic Agent
by Vergil H. Ferm*
Sodium arsenate induces developmental malformations in a variety of experimental animals. In the
golden hamster, the intravenous (or intraperitoneal) administration of 20 mg/kg of sodium arsenate
during day 8 to 9 ofgestation induces a rather specific spectrum ofcongenital malformations. This period
corresponds to the period of very rapid differentiation and major organogenesis in this animal. The
spectrum of defects produced by arsenate in the hamster includes exencephaly, encephaloceles, skeletal
defects, and malformations of the genito-urinary system. This teratogenic effect can be significantly
reduced by the simultaneous administration of selenium. Recent studies in this laboratory have demon-
strated the permeability ofthe placenta to 74As during the early critical stages ofembryogenesis and the
distribution of this isotope in maternal, placental and embryonic tissues. We have also recently demon-
strated the marked potentlation ofthe teratogenic effect ofsodium arsenate by subjecting the mothers to
short periods of hyperthermia immediately following the administration of subteratogenic or minimal
teratogenic levels of arsenate.
Introduction
Arsenic has been known for some time to have a
deleterious effect on the developing vertebrate em-
bryo. Ancel (I) first demonstrated that disodium
methylarsenate interfered with tailbud development
of the chick embryo. Subsequently, Ridgway and
Karnofsky (2) showed that sodium orthoarsenate
caused mild micromelia and abdominal edema when
injected into the yolk sac of 4-day chick embryos.
We first demonstrated the clear-cut mammalian
teratogenic effect ofsodium arsenate in the hamster
in 1968 (3). These findings have been confirmed in
the mouse (4) and rat (5).
Animal Model
We began to study the effects of sodium arsenate
on the developing hamster embryo, utilizing the
teratogenic screening model employed in this
laboratory for a number of years. Our model con-
sists of breeding the animals under laboratory con-
ditions to obtain accurately timed matings and then
injecting the animals either intravenously or in-
traperitoneally on day 8 ofgestation. At this time of
development the embryo has implanted and is be-
ginning to undergo axial orientation. Differentiation
immediately thereafter is extremely rapid and pro-
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gresses through the stages ofsomite differentiation,
neural tube closure, visceral arch formation, limb
bud formation, and embryonic heartbeat, all within
a 24-hr period. Our first experiments with sodium
arsenate showed that the toxic level (the amount
which would kill all of the embroys in utero) was
somewhere over 30 mg/kg of this salt. Dosage
levels of 10 mg/kg induced minimal teratogenic ef-
fects. The optimal teratogenic dose (the one causing
approximately 50% fetal resorption and a large per-
centage of malformation in the surviving embryos)
was determined to be 20 mg/kg of sodium arsenate.
Because we had determined that certain other
metals (lead, cadmium, and indium), induced rather
specific teratogenic effects in this same animal sys-
tem (6) it was of interest to find that sodium arse-
nate, when injected on day 8 ofgestation, induced a
high percentage ofexencephaly in fetuses as well as
a number of fetuses with varying degrees of en-
cephaloceles. When the time of injection is varied,
that is when the injections are spread out over the
24-hr period between days 8 and 9 of gestation, the
spectrum of malformations changes. This probably
means that the organ systems undergoing differen-
tation are also changing at this time and are appar-
ently sensitive to the amount of arsenic to which
they are exposed.
We discovered quite early that one ofthe peculiar
teratogenic effects ofsodium arsenate was its effect
on the developing urogenital system. Careful dis-
sections of fetuses recovered from mothers treated
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of urogenital anomalies. These were not restricted
to one sex and consisted of malformations of the
uterus, ovaries, and testes, together with a rather
high incidence of unilateral and even bilateral renal
agenesis. We as yet have no explanation for this and
have not noted this in animals treated with other
metals.
Protective Effect of Selenium
Early in our experimental work with arsenic in
combination with various metals, we noted that
selenium had a marked protective effect against the
teratogenic effect of arsenic. Selenium in itself is
not a significant teratogen in our animal model.
However, when injected into pregnant animals
which have received arsenic shortly before, the
selenium significantly reduces the teratogenic re-
sponse (7). It might be added here that selenium has
this same protective effect on cadmium-induced
developmental malformations.
Synteratogenic Effect of Hyper-
thermia and Sodium Arsenate
The remarkable consistency of malformations of
the brain induced by arsenic are quite striking. Re-
cently, we noted that similar malformations could
be induced in hamster embryos when the mothers
were exposed to a hyperthermic environment on
day 8 of gestation (8). Essentially these animals
were kept in a darkened incubator for a period of 1
to 1.25 hr and the temperature raised to approxi-
mately 41°C. Pretreatment and post-treatment rec-
tal temperatures were recorded on these animals
and then the embryos recovered some 4 to 5 days
later. Those embryos recovered from treated
mothers showed a high incidence ofencephaloceles
and exencephaly. Reducing the time of exposure to
the hyperthermic treatment reduced the number of
malformations. Times above this caused almost
complete fetal absorption. Therefore the exposure
time of 1.25 hr seemed to be fairly critical.
Utilizing the minimal teratogenic dose of 10
mg/kg of sodium arsenate we then exposed the ani-
mals to the subteratogenic dose (I hr) of hyper-
thermia. Whereas neither ofthese treatments alone
would cause many malformations in the offspring,
the additive effect of these two stimuli was clearly
demonstrated by the increased incidence of mal-
formations in those embryos exposed to the syner-
gistic treatment. Several explanations may account
for this. One is that the increased heat stress causes
an increase in the permeability of the placenta so
that more arsenic ions are available to the develop-
ing embryo; another is that the fever induced by this
treatment may accelerate chemical reactions in
general and thus potentiate the arsenic effect; and
finally, because actively dividing cells are known to
be more sensitive to both heat and arsenic, the addi-
tive effect may be simply one involving a suppres-
sion of mitotic activity. Limarzi (9) has shown that
arsenic causes abnormal mitotic figures and
chromosome scattering in human bone marrow
cells, and Edwards (10) has shown that exposure of
pregnant guinea pigs to hyperthermia caused inhibi-
tion of mitotic activity and subsequent cell death in
fetuses.
Permeability of the Placenta
to Arsenic
The permeability of the placenta to arsenic has
always been of some interest and certainly so when
one tries to explain the teratogenic effect of this
agent on developing tissues. T-he transmission of
organic arsenicals from pregnant rabbits and cats to
their fetuses apparently is negligible as demon-
strated by the studies of Underhill and Armatruda
(11), although the stages ofembryonic development
were not correlated with the times of injection.
Snyder and Speert (12), however, concluded that
the rate oftransmission ofneoarsphenamine across
the rabbit placenta increased as pregnancy pro-
gressed. Term human placentas from patients re-
ceiving the therapeutic doses of prenatal arsphen-
amine showed a greater retention of arsenic in the
fetal portion ofthe placenta as compared to the ma-
ternal portion (13). Lugo et al. (14) have docu-
mented a human case of arsenic trioxide poisoning
in human pregnancy, and has shown the ease with
which inorganic arsenic crosses the human placenta
at term with extremely high levels in the fetal liver,
brain and kidneys. James et al. (15) showed that
potassium arsenate given to pregnant ewes appar-
ently did not accumulate in detectable amounts in
the lambs of ewes fed potassium arsenate during
pregnancy, but only four animals were checked fol-
lowing dietary treatment.
We recently have studied the placental transmis-
sion of 74As in the teratogenic model we use in this
laboratory (Hanlon and Ferm, unpublished data).
Pregnant hamsters on day 8 of gestation were in-
jected intravenously with a teratogenic dose of
sodium arsenate (20 mg/kg) to which had been
added a known amount of radioactive arsenic. Ma-
ternal and embryonic tissues were collected either
24 or 96 hr later. The tissues were then counted for
radioactivity and it was clear that arsenic traversed
the placenta during the critical stage of em-
bryogenesis and appeared in the embryonic tissues.
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rather rapid clearance of this isotope from the tis-
sues. It is significant to note, however, that a fair
amount of arsenic did cross the placenta and is
available to the embryonic tissues during the critical
states ofembryogenesis ifthis is indeed the manner
ofits teratogenic activity.
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